Greengard, Paul

(redirected from Paul Greengard)
Also found in: Encyclopedia, Wikipedia.


Paul, U.S. biochemist, 1925–, joint winner of 2000 Nobel Prize for work related to nervous system signal transduction.
References in periodicals archive ?
Paul Greengard directs the Foundation's team of scientists who have been at the forefront of Alzheimer's research, providing the conceptual framework for understanding the disease.
Paul Greengard and his team of scientists, in collaboration with other leading research institutions around the world.
began by commercializing technologies developed in the laboratory of its Co-Founder and Nobel Laureate, Paul Greengard, Ph.
This ground-breaking study represents not only an encouraging first step in the development of a promising new approach to Parkinson's disease therapy, but also provides a platform to translate a variety of new gene therapy agents into human clinical trials for many devastating brain disorders," said Paul Greengard, PhD, chairman of the Neurologix Scientific Advisory Board and recipient of the 2000 Nobel Prize for Physiology or Medicine for his work related to how brain cells communicate.
Paul Greengard, a recipient of the 2000 Nobel Prize in Physiology or Medicine and Vincent Astor Professor at The Rockefeller University, and his wife, celebrated Brooklyn sculptor Ursula von Rydingsvard.
Paul Greengard, Nobel Laureate, Vincent Astor Professor and Head of the Laboratory of Molecular and Cellular Neuroscience at Rockefeller University, and Chairman of the Neurologix Scientific Advisory Board, commented, "The initial results of the trial are very encouraging.
Neurologix also noted that at the Berlin conference, Nobel Laureate Paul Greengard, the chairman of its Scientific Advisory Board, gave the keynote address at the opening ceremonies of the meeting and Dr.
Their names were put forward for the award by Paul Greengard, winner of the 2000 Nobel Prize in Medicine and a professor at The Rockefeller University, Alexander Varshavsky, professor at the California Institute of Technology and 2011 BBVA Foundation Frontiers of Knowledge laureate in Biomedicine, and Robert E.
formerly Discovery Therapeutics), announced today that Paul Greengard, Ph.